L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons

Brain Research

Volumn 771, Issue 1, 1997, Pages 159-162

  Maeda, Takehiko ^a   Cheng, Neng Neng ^a   Kume, Toshiaki ^a   Kaneko, Satoshi ^a   Kouchiyama, Hanae ^a   Akaike, Akinori ^a   Ueda, Mutsuaki ^a   Satoh, Masamichi ^a   Goshima, Yoshio ^b   Misu, Yoshimi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Culture; Glutamate; L DOPA; Neuroprotection; Neurotoxicity; Release; Striatum

Indexed keywords

CALCIUM ION; GLUTAMIC ACID; LEVODOPA; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TETRODOTOXIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CULTURE MEDIUM; CYTOTOXICITY; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CELL DEATH; CELLS, CULTURED; CORPUS STRIATUM; CULTURE MEDIA; FETUS; GLUTAMIC ACID; LEVODOPA; MAGNESIUM; NEURONS; NEUROTOXINS; RATS; RATS, WISTAR; TETRODOTOXIN;

EID: 0030702050     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00908-6     Document Type: Article

References (13)

1. Amano T., Ujihara H., Matsubayashi H., Sasa M., Yokota T., Tamura Y., Akaike A. Dopamine-induced protection of striatal neurons against kainate receptor-mediated cytotoxicity in vitro. Brain Res. 655:1994;61-69.
2. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. N. Cheng, T. Maeda, T. Kume, S. Kaneko, H. Kochiyama, A. Akaike, Y. Goshima, Y. Misu, Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons, Brain Res., in press.
4. 2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices. Brain Res. 617:1993;167-170.
5. Graham D.G. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;633-643.
6. Lindroth P., Mopper K. High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde. Anal. Chem. 51:1979;1667-1674.
7. Lloyd K.G., Davidson L., Hornykiewicz O. The neurochemistry of Parkinson's disease: effect of L-DOPA therapy. J. Pharmacol. Exp. Ther. 195:1975;453-464.
8. McGeer, McGeer Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid. Neurochem. Res. 3:1978;501-517.
9. Misu Y., Goshima Y. Is L-DOPA an endogenous neurotransmitter? Trends Pharmacol. Sci. 14:1993;119-123.
10. Misu Y., Ueda H., Goshima Y. Neurotransmitter-like actions of L-DOPA. Adv. Pharmacol. 32:1995;427-459.
11. Moore R.Y., Bloom F.E. Central catecholamine neuron system: anatomy and physiology of the dopamine systems. Annu. Rev. Neurosci. 1:1978;129-169.
12. 2 dopamine agonist synergism: separate sites of action? Trends Pharmacol. Sci. 8:1987;295-299.
13. Rossor M.N., Watkins J., Brown M.J., Reid J.L., Dollery C.T. Plasma levodopa, dopamine and therapeutic response following levodopa therapy of parkinsonian patients. Brain Res. 46:1980;385-392.